Depression, anxiety, psychotropic drugs, and acute myocardial infarction: large prospective study of United Kingdom women.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
03 2023
Historique:
medline: 4 4 2023
pubmed: 11 8 2021
entrez: 10 8 2021
Statut: ppublish

Résumé

Reported associations between depression and myocardial infarction in some studies might be explained by use of psychotropic drugs, residual confounding, and/or reverse causation (whereby heart disease precedes depression). We investigated these hypotheses in a large prospective study of UK women with no previous vascular disease. At baseline in median year 2001 (IQR 2001-2003), Million Women Study participants reported whether or not they were currently being treated for depression or anxiety, their self-rated health, and medication use during the previous 4 weeks. Follow-up was through linkage to national hospital admission and mortality databases. Cox regression yielded adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for the first myocardial infarction event in those reporting treatment for depression or anxiety (subdivided by whether or not the treatment was with psychotropic drugs) During mean follow-up of 13.9 years of 690 335 women (mean age 59.8 years) with no prior heart disease, stroke, transient ischaemic attack, or cancer, 12 819 had a first hospital admission or death from myocardial infarction. The aHRs for those reporting treatment for depression or anxiety with, and without, regular use of psychotropic drugs were 0.96 (95% CI 0.89-1.03) and 0.99 (0.89-1.11), respectively. No associations were found separately in women who reported being in good/excellent or poor/fair health or by length of follow-up. The null findings in this large prospective study are consistent with depression not being an independent risk factor for myocardial infarction.

Sections du résumé

BACKGROUND
Reported associations between depression and myocardial infarction in some studies might be explained by use of psychotropic drugs, residual confounding, and/or reverse causation (whereby heart disease precedes depression). We investigated these hypotheses in a large prospective study of UK women with no previous vascular disease.
METHODS
At baseline in median year 2001 (IQR 2001-2003), Million Women Study participants reported whether or not they were currently being treated for depression or anxiety, their self-rated health, and medication use during the previous 4 weeks. Follow-up was through linkage to national hospital admission and mortality databases. Cox regression yielded adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for the first myocardial infarction event in those reporting treatment for depression or anxiety (subdivided by whether or not the treatment was with psychotropic drugs)
RESULTS
During mean follow-up of 13.9 years of 690 335 women (mean age 59.8 years) with no prior heart disease, stroke, transient ischaemic attack, or cancer, 12 819 had a first hospital admission or death from myocardial infarction. The aHRs for those reporting treatment for depression or anxiety with, and without, regular use of psychotropic drugs were 0.96 (95% CI 0.89-1.03) and 0.99 (0.89-1.11), respectively. No associations were found separately in women who reported being in good/excellent or poor/fair health or by length of follow-up.
CONCLUSION
The null findings in this large prospective study are consistent with depression not being an independent risk factor for myocardial infarction.

Identifiants

pubmed: 34372954
doi: 10.1017/S0033291721003159
pii: S0033291721003159
pmc: PMC10009366
doi:

Substances chimiques

Psychotropic Drugs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1576-1582

Subventions

Organisme : Cancer Research UK
ID : 29186
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700474
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9900923
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K02700X/1
Pays : United Kingdom

Auteurs

Lianne Parkin (L)

Cancer Epidemiology Unit, Nuffield Department of Population Health, Richard Doll Building, Roosevelt Drive, University of Oxford, Oxford OX3 7LF, UK.
Department of Preventive and Social Medicine, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand.

Angela Balkwill (A)

Cancer Epidemiology Unit, Nuffield Department of Population Health, Richard Doll Building, Roosevelt Drive, University of Oxford, Oxford OX3 7LF, UK.

Jane Green (J)

Cancer Epidemiology Unit, Nuffield Department of Population Health, Richard Doll Building, Roosevelt Drive, University of Oxford, Oxford OX3 7LF, UK.

Gillian K Reeves (GK)

Cancer Epidemiology Unit, Nuffield Department of Population Health, Richard Doll Building, Roosevelt Drive, University of Oxford, Oxford OX3 7LF, UK.

Valerie Beral (V)

Cancer Epidemiology Unit, Nuffield Department of Population Health, Richard Doll Building, Roosevelt Drive, University of Oxford, Oxford OX3 7LF, UK.

Sarah Floud (S)

Cancer Epidemiology Unit, Nuffield Department of Population Health, Richard Doll Building, Roosevelt Drive, University of Oxford, Oxford OX3 7LF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH